Apex Biotechnology Corp (1733) — Cash Flow Reinvestment Rate
Apex Biotechnology Corp (1733) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting NT$9.17 Million (capex NT$2.97 Million plus investments NT$6.21 Million) from operating cash flow of NT$5.19 Million. Check Apex Biotechnology Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Apex Biotechnology Corp across 23 annual periods. Explore Apex Biotechnology Corp long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Apex Biotechnology Corp (2002–2024)
Year-by-year capital reinvestment analysis for Apex Biotechnology Corp. For live market cap and broader valuation context, see 1733 market cap.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | NT$35.63 Million | NT$328.67 Million | NT$29.63 Million | ▼ -47.4% |
| 2023 | 0.21x | NT$47.48 Million | NT$230.39 Million | NT$24.98 Million | ▼ -86.6% |
| 2022 | 1.54x | NT$40.90 Million | NT$26.62 Million | NT$40.20 Million | ▲ +880.3% |
| 2021 | 0.16x | NT$28.20 Million | NT$179.87 Million | NT$26.20 Million | ▼ -74.4% |
| 2020 | 0.61x | NT$171.51 Million | NT$280.60 Million | NT$48.32 Million | ▲ +112.3% |
| 2019 | 0.29x | NT$133.19 Million | NT$462.52 Million | NT$56.58 Million | ▼ -81.6% |
| 2018 | 1.56x | NT$105.52 Million | NT$67.57 Million | NT$75.29 Million | ▲ +312.9% |
| 2017 | 0.38x | NT$26.79 Million | NT$70.83 Million | NT$26.76 Million | ▲ +101.2% |
| 2016 | 0.19x | NT$56.03 Million | NT$298.06 Million | NT$38.45 Million | ▼ -5.2% |
| 2015 | 0.20x | NT$93.63 Million | NT$472.15 Million | NT$26.66 Million | ▼ -44.4% |
| 2014 | 0.36x | NT$95.47 Million | NT$267.60 Million | NT$65.41 Million | ▼ -40.9% |
| 2013 | 0.60x | NT$292.47 Million | NT$484.77 Million | NT$247.69 Million | ▼ -25.9% |
| 2012 | 0.81x | NT$414.70 Million | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$74.63 Million | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$161.05 Million | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$73.34 Million | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$129.74 Million | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$54.71 Million | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$41.99 Million | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$81.30 Million | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$251.16 Million | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$56.21 Million | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$61.13 Million | NT$79.49 Million | NT$61.13 Million | — |